A multi-center study led by Nicolai Franzmeier (ISD) and Rik Ossenkoppele (Amsterdam UMC) compiled the to date largest biomarker and post-mortem dataset on atypical Alzheimer’s disease, showing distinct tau onset sites and network-based spread, supporting trans-neuronal tau propagation and informing personalized medicine and trial endpoints.